Login
Cart
Support
Search
Search
Search
Paul Enck
Appearances
View Grid
WHO ARE THE PLACEBO RESPONDERS IN IBS CLINICAL TRIALS?: A PROSPECTIVE STUDY OF A PLACEBO-CONTROLLED MULTISITE NIH TRIAL
Date
May 8, 2023
BACKGROUND: Irritable bowel syndrome (IBS) is a common disorder with complex pathophysiological mechanisms. Prior studies suggest that 25-50% of patients with diarrhea-predominant IBS (IBS-D) have evidence of bile acid (BA) diarrhea (BAD)…
Presenter
Jeffrey Lackner
Speakers
Brian Quigley
Sigal Zilcha-Mano
Sarah Mason
Gregory Gudleski
Susan Krasner
Christopher Radziwon
Alison Vargovich
Patricia O'Leary
Paul Enck